Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Patent Expiration


About Veterinary Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin is used in a drug marketed by 1 company: Huvepharma Eood.

Other drugs containing Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin are: Optigrid and monovet and tylovet and mga , Actogain and monovet and tylovet and mga , Optigrid and monovet and tylovet and cycleguard , Actogain and monovet and tylan and mga

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Generic API Manufacturers

Given below is the list of companies who have filed for Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin generic, along with the locations of their manufacturing plants worldwide.